TFX vs TMO: fair value comparison
Teleflex Incorporated and Thermo Fisher Scientific Inc. · Updated 2026-09-12
TFX currently screens as undervalued while TMO screens as fairly valued. Within Healthcare, TFX currently sits closer to the top of our discount ranking.
| TFX | TMO | |
|---|---|---|
| Verdict | Undervalued | Fairly valued |
| Last price | $141.56 | $609.82 |
| 12-month range | $103.36–$140.48 | $469.21–$600.50 |
| Sector rank | #59 of 113 Healthcare | #64 of 113 Healthcare |
| Quality grade | C | C |
| Leverage | Moderate | Moderate |
| Margin trend | Contracting | Stable |
| Revenue growth | Declining | Modest |
| RSI zone | Neutral | Neutral |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: TFX fair value analysis · TMO fair value analysis